Biotech

Apiam Animal Health Limited (ASX:AHX) FY23 Results Announcement

🕔8/28/2023 8:14:36 AM

Apiam Animal Health Limited (ASX:AHX) today released its full year financial results for the year ended 30 June 2023 (FY23)

Read Full Article

Apiam Animal Health Limited (ASX:AHX) FY23 Reporting Date and Investor Webinar Notification

🕔8/22/2023 8:41:32 AM

Apiam Animal Health Limited (ASX:AHX) will release its financial results for the twelve months ended 30 June 2023 on Monday 28 August 2023.

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) Annual Report to Shareholders

🕔8/22/2023 7:55:46 AM

It has been a pivotal year for Proteomics International Laboratories Ltd (ASX:PIQ), with the signing of a landmark deal to bring our PromarkerD test for diabetic kidney disease to patients in the United States.

Read Full Article

Apiam Animal Health Limited (ASX:AHX) FY2023 Trading Update

🕔8/1/2023 10:11:58 AM

Apiam Animal Health Limited (ASX:AHX) today announced a market update ahead of the release of its financial results for the year ended 30 June 2023 (FY23).

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) Proteomics Presents at 17th Bioshares Biotech Summit

🕔7/25/2023 9:08:16 AM

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to release a copy of the presentation to be provided by Dr Richard Lipscombe to delegates at the 17th Bioshares Biotech Summit on 25 July 2023.

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) June 2023 Quarterly Activities Report

🕔7/24/2023 9:27:43 AM

Proteomics International Laboratories Ltd (ASX:PIQ), a medical technology company at the forefront of precision medicine and predictive diagnostics, is pleased to provide the following update on its business activities for the three months to 30 June 2023 and subsequent to the period end.

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) Promarker Pipeline - Oesophageal Cancer Diagnostic Update

🕔7/20/2023 8:21:05 AM

Proteomics International Laboratories Ltd (ASX:PIQ) has been invited to present the latest results from its novel blood test for oesophageal adenocarcinoma at the 19th ISDE World Congress for Esophageal Diseases in Toronto, Canada, 8-10 September 2023.

Read Full Article